DEFITELIO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Defibrotide Sodium.
| Product ID | 68727-800_0173efe0-e4e2-41f6-b044-81f707120906 |
| NDC | 68727-800 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DEFITELIO |
| Generic Name | Defibrotide Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2016-03-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208114 |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | DEFIBROTIDE SODIUM |
| Active Ingredient Strength | 80 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208114 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-03-30 |
| Marketing Category | NDA |
| Application Number | NDA208114 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-03-30 |
| Ingredient | Strength |
|---|---|
| DEFIBROTIDE SODIUM | 80 mg/mL |
| SPL SET ID: | 2c3db989-d7ad-41ed-9ebf-698dcf6c24ec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEFITELIO 87638258 5652544 Live/Registered |
Gentium S.r.l. 2017-10-09 |
![]() DEFITELIO 87034509 5487126 Live/Registered |
Gentium S.r.l. 2016-05-12 |
![]() DEFITELIO 79099301 4162914 Live/Registered |
Gentium S.r.l. 2011-05-16 |